TWiV 764: COVID-19 clinical update #65 with Dr. Daniel Griffin

In COVID-19 clinical update #65, Daniel Griffin summarizes effects of non-pharmaceutical interventions, updated summer camp guidance from CDC, serology testing not recommended by FDA, antigen tests during a music event, inhibition of vaccine immunogenicity by methotrexate, phase 3 trial results for colchicine, and small airway disease as a post-acute sequelae.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

• Effects of vaccines and NPIs (JAMA)
• Guidance on summer camps (CDC)
• Antibody testing not recommended (FDA)
• Antigen testing at a music event (Lancet)
• Methotrexate and vaccine immunogenicity (Ann Rheum Dis)
• Colchicine phase 3 results (Lancet Resp Med)
• Small airway disease a post-acute sequelae (medRxiv)
• Letters read on TWiV 764
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]